Acute Control of Chronic Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The investigators seek to asses the effect of preexisting hypertension on the patient's response to treatment for severe hypertension in preeclampsia with severe features. The investigators hypothesize that successive administration of 40‐60‐80 mg of labetolol will reduce time to blood pressure control versus the standard dosing, 20‐40‐80 mg labetolol, recommended by the American College of Obstetricians and Gynecologists in 2015.
Epistemonikos ID: 17d4ab6a45e36d3bce83443ab1366bff82e83e71
First added on: May 22, 2024